tiprankstipranks
Hca Healthcare (CH:2BH)
NYSE:2BH
Switzerland Market
2BH
HCA Healthcare
RESEARCH TOOLSreports

HCA Healthcare (2BH) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

2BH Analyst Ratings

Moderate Buy
13Ratings
Moderate Buy
9 Buy
4 Hold
0 Sell
Based on 13 analysts giving stock ratings to
HCA
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2BH Stock 12 Month Forecast

Average Price Target

$395.72
Based on 13 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $395.72 with a high forecast of $452.33 and a low forecast of $334.79. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$452.33Average Price Target$395.72Lowest Price Target$334.79
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on CH:2BH
Ryan Langston
TD Cowen
TD Cowen
CHF315.78→CHF349.38
Buy
―
Reiterated
06/25/26
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Icon (NASDAQ: ICLR)
Goldman Sachs Analyst forecast on CH:2BH
Scott Fidel
Goldman Sachs
Goldman Sachs
CHF452.33
Buy
―
Reiterated
06/11/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Bernstein Analyst forecast on CH:2BH
Lance Wilkes
Bernstein
Bernstein
CHF334.79
Hold
―
Reiterated
06/09/26
Bernstein Reaffirms Their Hold Rating on HCA Healthcare (HCA)
Bank of America Securities Analyst forecast on CH:2BH
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
CHF389.1→CHF336.41
Hold
―
Reiterated
06/09/26
HCA Healthcare price target lowered to $415 from $480 at BofAHCA Healthcare price target lowered to $415 from $480 at BofA
Barclays Analyst forecast on CH:2BH
Andrew Mok CFA
Barclays
Barclays
CHF402.07
Buy
―
Reiterated
06/08/26
Barclays Sticks to Its Buy Rating for HCA Healthcare (HCA)
Truist Financial Analyst forecast on CH:2BH
David S Macdonald
Truist Financial
Truist Financial
―
Buy
―
Reiterated
05/28/26
Analysts Are Bullish on Top Healthcare Stocks: Insulet (PODD), Privia Health Group (PRVA)
J.P. Morgan Analyst forecast on CH:2BH
Benjamin Rossi
J.P. Morgan
J.P. Morgan
CHF397.21
Hold
―
Reiterated
05/22/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (NYSE: HCA) and Zai Lab (NASDAQ: ZLAB)
Stephens Analyst forecast on CH:2BH
Unknown Analyst
Stephens
Not Ranked
Stephens
CHF429.63
Buy
―
Assigned
04/27/26
HCA Healthcare price target lowered to $530 from $560 at StephensHCA Healthcare price target lowered to $530 from $560 at Stephens
Oppenheimer Analyst forecast on CH:2BH
Michael Wiederhorn
Oppenheimer
Oppenheimer
CHF437.74→CHF421.53
Buy
―
Assigned
04/27/26
HCA Healthcare price target lowered to $520 from $540 at OppenheimerHCA Healthcare price target lowered to $520 from $540 at Oppenheimer
Wells Fargo Analyst forecast on CH:2BH
Stephen Baxter
Wells Fargo
Wells Fargo
CHF389.91→CHF353.43
Hold
―
Assigned
04/27/26
HCA: Baxter Maintains Hold as Soft Underlying Trends Prompt Trimmed EBITDA Outlook and Price Target Cut to $436
KeyBanc Analyst forecast on CH:2BH
Matthew Gillmor CFA
KeyBanc
KeyBanc
CHF445.85→CHF413.42
Buy
―
Reiterated
04/27/26
Analysts Offer Insights on Healthcare Companies: ICU Medical (NASDAQ: ICUI), HCA Healthcare (NYSE: HCA) and Eli Lilly & Co (NYSE: LLY)
RBC Capital Analyst forecast on CH:2BH
Ben Hendrix
RBC Capital
RBC Capital
CHF480.7→CHF432.88
Buy
―
Reiterated
04/26/26
RBC Capital Keeps Their Buy Rating on HCA Healthcare (HCA)
Jefferies Analyst forecast on CH:2BH
Brian Tanquilut
Jefferies
Jefferies
CHF478.27→CHF425.58
Buy
―
Reiterated
04/24/26
HCA Healthcare price target lowered to $525 from $590 at JefferiesHCA Healthcare price target lowered to $525 from $590 at Jefferies
Mizuho Securities Analyst forecast on CH:2BH
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF437.74→CHF474.22
Buy
―
Reiterated
02/25/26
HCA Healthcare price target raised to $585 from $540 at MizuhoHCA Healthcare price target raised to $585 from $540 at Mizuho
UBS Analyst forecast on CH:2BH
A.J. Rice
UBS
UBS
CHF484.76→CHF514.75
Buy
―
Reiterated
02/23/26
HCA Healthcare price target raised to $635 from $598 at UBSHCA Healthcare price target raised to $635 from $598 at UBS
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on CH:2BH
Ryan Langston
TD Cowen
TD Cowen
CHF315.78→CHF349.38
Buy
―
Reiterated
06/25/26
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Icon (NASDAQ: ICLR)
Goldman Sachs Analyst forecast on CH:2BH
Scott Fidel
Goldman Sachs
Goldman Sachs
CHF452.33
Buy
―
Reiterated
06/11/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Bernstein Analyst forecast on CH:2BH
Lance Wilkes
Bernstein
Bernstein
CHF334.79
Hold
―
Reiterated
06/09/26
Bernstein Reaffirms Their Hold Rating on HCA Healthcare (HCA)
Bank of America Securities Analyst forecast on CH:2BH
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
CHF389.1→CHF336.41
Hold
―
Reiterated
06/09/26
HCA Healthcare price target lowered to $415 from $480 at BofAHCA Healthcare price target lowered to $415 from $480 at BofA
Barclays Analyst forecast on CH:2BH
Andrew Mok CFA
Barclays
Barclays
CHF402.07
Buy
―
Reiterated
06/08/26
Barclays Sticks to Its Buy Rating for HCA Healthcare (HCA)
Truist Financial Analyst forecast on CH:2BH
David S Macdonald
Truist Financial
Truist Financial
―
Buy
―
Reiterated
05/28/26
Analysts Are Bullish on Top Healthcare Stocks: Insulet (PODD), Privia Health Group (PRVA)
J.P. Morgan Analyst forecast on CH:2BH
Benjamin Rossi
J.P. Morgan
J.P. Morgan
CHF397.21
Hold
―
Reiterated
05/22/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (NYSE: HCA) and Zai Lab (NASDAQ: ZLAB)
Stephens Analyst forecast on CH:2BH
Unknown Analyst
Stephens
Not Ranked
Stephens
CHF429.63
Buy
―
Assigned
04/27/26
HCA Healthcare price target lowered to $530 from $560 at StephensHCA Healthcare price target lowered to $530 from $560 at Stephens
Oppenheimer Analyst forecast on CH:2BH
Michael Wiederhorn
Oppenheimer
Oppenheimer
CHF437.74→CHF421.53
Buy
―
Assigned
04/27/26
HCA Healthcare price target lowered to $520 from $540 at OppenheimerHCA Healthcare price target lowered to $520 from $540 at Oppenheimer
Wells Fargo Analyst forecast on CH:2BH
Stephen Baxter
Wells Fargo
Wells Fargo
CHF389.91→CHF353.43
Hold
―
Assigned
04/27/26
HCA: Baxter Maintains Hold as Soft Underlying Trends Prompt Trimmed EBITDA Outlook and Price Target Cut to $436
KeyBanc Analyst forecast on CH:2BH
Matthew Gillmor CFA
KeyBanc
KeyBanc
CHF445.85→CHF413.42
Buy
―
Reiterated
04/27/26
Analysts Offer Insights on Healthcare Companies: ICU Medical (NASDAQ: ICUI), HCA Healthcare (NYSE: HCA) and Eli Lilly & Co (NYSE: LLY)
RBC Capital Analyst forecast on CH:2BH
Ben Hendrix
RBC Capital
RBC Capital
CHF480.7→CHF432.88
Buy
―
Reiterated
04/26/26
RBC Capital Keeps Their Buy Rating on HCA Healthcare (HCA)
Jefferies Analyst forecast on CH:2BH
Brian Tanquilut
Jefferies
Jefferies
CHF478.27→CHF425.58
Buy
―
Reiterated
04/24/26
HCA Healthcare price target lowered to $525 from $590 at JefferiesHCA Healthcare price target lowered to $525 from $590 at Jefferies
Mizuho Securities Analyst forecast on CH:2BH
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF437.74→CHF474.22
Buy
―
Reiterated
02/25/26
HCA Healthcare price target raised to $585 from $540 at MizuhoHCA Healthcare price target raised to $585 from $540 at Mizuho
UBS Analyst forecast on CH:2BH
A.J. Rice
UBS
UBS
CHF484.76→CHF514.75
Buy
―
Reiterated
02/23/26
HCA Healthcare price target raised to $635 from $598 at UBSHCA Healthcare price target raised to $635 from $598 at UBS
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HCA Healthcare

3 Months
Whit MayoLeerink Partners
Success Rate
31/46 ratings generated profit
67%
Average Return
+6.29%
Copying Whit Mayo's trades and holding each position for 3 Months would result in 67.39% of your transactions generating a profit, with an average return of +6.29% per trade.
1 Year
Scott FidelGoldman Sachs
Success Rate
24/27 ratings generated profit
89%
Average Return
+18.21%
Copying Scott Fidel's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +18.21% per trade.
2 Years
Whit MayoLeerink Partners
Success Rate
43/46 ratings generated profit
93%
Average Return
+49.90%
Copying Whit Mayo's trades and holding each position for 2 Years would result in 93.48% of your transactions generating a profit, with an average return of +49.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2BH Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
22
23
17
15
16
Hold
11
11
9
9
11
Sell
2
2
0
0
0
Strong Sell
0
0
0
0
0
total
35
36
26
24
27
In the current month, 2BH has received 16 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. 2BH average Analyst price target in the past 3 months is 395.72.
Each month's total comprises the sum of three months' worth of ratings.

2BH Financial Forecast

2BH Earnings Forecast

Next quarter’s earnings estimate for 2BH is $5.97 with a range of $5.52 to $6.17. The previous quarter’s EPS was $5.80. 2BH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 2BH has Performed in-line its overall industry.
Next quarter’s earnings estimate for 2BH is $5.97 with a range of $5.52 to $6.17. The previous quarter’s EPS was $5.80. 2BH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 2BH has Performed in-line its overall industry.

2BH Sales Forecast

Next quarter’s sales forecast for 2BH is $15.73B with a range of $15.23B to $16.20B. The previous quarter’s sales results were $15.51B. 2BH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 2BH has Performed in-line its overall industry.
Next quarter’s sales forecast for 2BH is $15.73B with a range of $15.23B to $16.20B. The previous quarter’s sales results were $15.51B. 2BH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 2BH has Performed in-line its overall industry.

2BH Stock Forecast FAQ

What is CH:2BH’s average 12-month price target, according to analysts?
Based on analyst ratings, Hca Healthcare’s 12-month average price target is 395.72.
    What is CH:2BH’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:2BH, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Hca Healthcare a Buy, Sell or Hold?
        Hca Healthcare has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 4 hold ratings and 0 sell ratings.
          What is Hca Healthcare’s share price target?
          The average share price target for Hca Healthcare is 395.72. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $452.33 ,and the lowest forecast is $334.79. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Hca Healthcare?
            Hca Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
              How can I buy shares of Hca Healthcare?
              To buy shares of CH:2BH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.